{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:12:01Z","timestamp":1791465121504,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11046-021-00564-y","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T14:02:41Z","timestamp":1626357761000},"page":"499-505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["COVID-19-Associated Pulmonary Aspergillosis at an Academic Medical Center in the Midwestern United States"],"prefix":"10.1007","volume":"186","author":[{"given":"Anastasia I.","family":"Wasylyshyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Rostyslaw","family":"Wasylyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Linder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3175-0512","authenticated-orcid":false,"given":"Marisa H.","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"issue":"6","key":"564_CR1","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367\u201376.","journal-title":"Clin Infect Dis"},{"key":"564_CR2","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1080\/13693780600919262","volume":"44","author":"KH Vandewoude","year":"2006","unstructured":"Vandewoude KH, Vogelaers D, Blot SI. Aspergillosis in the ICU: the new 21st century problem? Med Mycol. 2006;44:S71\u20136.","journal-title":"Med Mycol"},{"issue":"1","key":"564_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","volume":"186","author":"SI Blot","year":"2012","unstructured":"Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Resp Crit Care Med. 2012;186(1):56\u201364.","journal-title":"Am J Resp Crit Care Med"},{"issue":"10","key":"564_CR4","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","volume":"6","author":"AFAD Schauwvlieghe","year":"2018","unstructured":"Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Resp Med. 2018;6(10):782\u201392.","journal-title":"Lancet Resp Med"},{"issue":"7","key":"564_CR5","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/cid\/ciaa007","volume":"71","author":"IS Schwartz","year":"2020","unstructured":"Schwartz IS, Friedman DZP, Zapernick L, Dingle TC, Lee N, et al. High rates of influenza-associated invasive pulmonary aspergillosis may not be universal: a retrospective cohort study from Alberta, Canada. Clin Infect Dis. 2020;71(7):1760\u20133.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"564_CR6","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/myc.13096","volume":"63","author":"P Koehler","year":"2020","unstructured":"Koehler P, Cornely OA, B\u00f6ttiger BW, Dusse F, Eichenauer DA, Fuchs F, et al. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020;63(6):528\u201334.","journal-title":"Mycoses"},{"issue":"6","key":"564_CR7","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","volume":"8","author":"A Alanio","year":"2020","unstructured":"Alanio A, Delli\u00e8re S, Fodil S, Bretagne S, M\u00e9garbane B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020;8(6):e48\u20139. https:\/\/doi.org\/10.1016\/S2213-2600(20)30237-X.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"564_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","volume":"202","author":"ALE van Arkel","year":"2020","unstructured":"van Arkel ALE, Rijpstra TA, Belderbos HNA, van Wijngaarden P, Verweij PE, Bentvelsen RG. COVID-19-associated pulmonary aspergillosis. Am J Respir Crit Care Med. 2020;202(1):132\u20135. https:\/\/doi.org\/10.1164\/rccm.202004-1038LE.","journal-title":"Am J Respir Crit Care Med"},{"key":"564_CR9","doi-asserted-by":"crossref","unstructured":"Salmanton-Garc\u00eda J, Sprute R, Stemler J, Bartoletti M, Dupont D, Valerio M, et al. COVID-19-associated pulmonary aspergillosis, March\u2013August 2020. Emerging Infect Dis, 27(4), 1077\u201386.","DOI":"10.3201\/eid2704.204895"},{"key":"564_CR10","doi-asserted-by":"publisher","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Lopes Colombo A, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis 2020 Dec; online ahead of print. https:\/\/doi.org\/10.1016\/S1473-3099(20)30847-1.","DOI":"10.1016\/S1473-3099(20)30847-1"},{"key":"564_CR11","doi-asserted-by":"publisher","unstructured":"Bartoletti M, Pasclae R, Cricca M, Rinaldi M, Maccaro A, Bussini L, et al. Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study. Clin Infect Dis 2020; ciaa1065. Online ahead of print. doi: https:\/\/doi.org\/10.1093\/cid\/ciaa1065.","DOI":"10.1093\/cid\/ciaa1065"},{"issue":"8","key":"564_CR12","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/myc.13135","volume":"63","author":"N Nasir","year":"2020","unstructured":"Nasir N, Farooqi J, Mahmood SF, Jabeen K. COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: an observational study from Pakistan. Mycoses. 2020;63(8):766\u201370.","journal-title":"Mycoses"},{"issue":"12","key":"564_CR13","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.cmi.2020.07.010","volume":"26","author":"F Lamoth","year":"2020","unstructured":"Lamoth F, Glampedakis E, Boillat-Blanco N, Oddo M, Pagani JL. Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients. Clin Microbiol Infect. 2020;26(12):1706\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"564_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3201\/eid2701.202896","volume":"27","author":"KA Marr","year":"2020","unstructured":"Marr KA, Platt A, Tornheim JA, Zhang SX, Datta K, Cardozo C, et al. Aspergillosis complicating severe coronavirus disease. Emerg Infect Dis. 2020;27(1):18\u201325.","journal-title":"Emerg Infect Dis"},{"key":"564_CR15","doi-asserted-by":"publisher","unstructured":"Crum-Cianflone NF. Invasive aspergillosis associated with severe influenza infections. Open Forum Infect Dis 2016; 3(3):ofw171. doi: https:\/\/doi.org\/10.1093\/ofid\/ofw171.","DOI":"10.1093\/ofid\/ofw171"},{"issue":"6","key":"564_CR16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/QCO.0000000000000504","volume":"31","author":"L Vanderbeke","year":"2018","unstructured":"Vanderbeke L, Spriet I, Breynaert C, Rijnders BJA, Verweij PE, Wauters J. Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis, and treatment. Curr Opin Infect Dis. 2018;31(6):471\u201380.","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"564_CR17","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","volume":"71","author":"X Chen","year":"2020","unstructured":"Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, et al. Detectable serum SARS-CoV-2 viral load (RNAemia) is closely correlated with drastically interleukin 6 (IL-6) level in critically ill COVID-19 patients. Clin Infect Dis. 2020;71(8):1937\u201342.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"564_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/modpathol.3800247","volume":"18","author":"DM Hwang","year":"2005","unstructured":"Hwang DM, Chamberlain DW, Poutanen SM, Low DE, Asa SL, Butany J. Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathology. 2005;18(1):1\u201310.","journal-title":"Mod Pathology"},{"issue":"5","key":"564_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJM200307313490519","volume":"349","author":"H Wang","year":"2003","unstructured":"Wang H, Ding Y, Li X, Yang L, Zhang W, Kang W. Fatal aspergillosis in a patient with SARS who was treated with corticosteroids. N Engl J Med. 2003;349(5):507\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"564_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/jof6020091","volume":"6","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar A, Carvalho A, van de Veerdonk FL, Jenks JD, Koehler P, Krause R, et al. COVID-19 associated pulmonary aspergillosis (CAPA)- from immunology to treatment. J Fungi. 2020;6(2):91. https:\/\/doi.org\/10.3390\/jof6020091.","journal-title":"J Fungi"},{"issue":"7","key":"564_CR21","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/cid\/ciaa010","volume":"71","author":"BJA Rjinders","year":"2020","unstructured":"Rjinders BJA, Schauwvlieghe AFAD, Wauters J. Influenza-associated pulmonary aspergillosis: a local or global lethal combination? Clin Infect Dis. 2020;71(7):1764\u20137.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"564_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13054-020-2808-8","volume":"24","author":"K Thevissen","year":"2020","unstructured":"Thevissen K, Jacobs C, Holtappels M, Toda M, Verweij P, Wauters J. International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe. Crit Care. 2020;24(1):84. https:\/\/doi.org\/10.1186\/s13054-020-2808-8.","journal-title":"Crit Care"},{"issue":"5","key":"564_CR23","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1086\/322793","volume":"184","author":"E Cenci","year":"2001","unstructured":"Cenci E, Mencacci A, Casagrande A, Mosci P, Bistoni F, Romani L. Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis. J Infect Dis. 2001;184(5):610\u20137.","journal-title":"J Infect Dis"},{"key":"564_CR24","doi-asserted-by":"publisher","unstructured":"Somers EC, Eschenauer GA, Troost JP, Golob JL, Gandhi TN, Wang L, et al. Tocilizumab for treatment of mechanically ventilated patients with COVID-19. Clin Infect Dis 2020; ciaa954. Epub ahead of print. doi: https:\/\/doi.org\/10.1093\/cid\/ciaa954.","DOI":"10.1093\/cid\/ciaa954"},{"key":"564_CR25","doi-asserted-by":"crossref","unstructured":"Humphreys H. Positive-pressure isolation and the prevention of invasive aspergillosis. What is the evidence? J Hosp Infect 2004 Feb; 56(2):93\u2013100.","DOI":"10.1016\/j.jhin.2003.10.011"},{"issue":"4","key":"564_CR26","doi-asserted-by":"publisher","first-page":"2002554","DOI":"10.1183\/13993003.02554-2020","volume":"56","author":"D Armstrong-James","year":"2020","unstructured":"Armstrong-James D, Youngs J, Bicanic T, Abdolrasouli A, Denning DW, Johnson E, et al. Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. Eur Resp J. 2020;56(4):2002554. https:\/\/doi.org\/10.1183\/13993003.02554-2020.","journal-title":"Eur Resp J"},{"key":"#cr-split#-564_CR27.1","unstructured":"CDC [Internet]. Interrim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic [updated 2020 December 14"},{"key":"#cr-split#-564_CR27.2","unstructured":"cited 2021 January 20]. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/infection-control-recommendations.html#anchor_1604360738701."},{"key":"564_CR28","doi-asserted-by":"crossref","unstructured":"Demuyser T, De Cock E, Sermijn E. Airborne Aspergillus fumigatus contamination in an intensive care unit: detection, management, and control. J Infect Public Health 2019; 12(6):904\u20136.","DOI":"10.1016\/j.jiph.2019.04.016"},{"key":"564_CR29","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/s13054-020-03221-w","volume":"24","author":"P Ichai","year":"2020","unstructured":"Ichai P, Saliba F, Baune P, Daoud A, Coilly A, Samuel D. Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients. Crit Care. 2020;24:538\u201340.","journal-title":"Crit Care"},{"key":"564_CR30","doi-asserted-by":"publisher","unstructured":"RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med 2020; NEJMoa2021436. Online ahead of print. doi: https:\/\/doi.org\/10.1056\/NEJMoa2021436.","DOI":"10.1056\/NEJMoa2021436"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-021-00564-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-021-00564-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-021-00564-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T17:40:45Z","timestamp":1627062045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-021-00564-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["564"],"URL":"https:\/\/doi.org\/10.1007\/s11046-021-00564-y","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"22 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"M.H.M. has received research support and consulting honoraria from Astellas US, Scynexis, Inc. and Mayne Pharma A.I.W., G.R.W. and K.A.L. have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Anastasia I. Wasylyshyn contributed to data collection, methodology, data curation, writing\u2014original draft preparation. G. Rostyslaw Wasylyshyn contributed to data collection, writing\u2014original draft preparation. Kathleen A. Linder contributed to validation, writing\u2014reviewing and editing. Marisa H. Miceli contributed to conceptualization, methodology, writing\u2014reviewing and editing.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"CRediT Author Statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}